London Daily

Focus on the big picture.
Monday, Jul 21, 2025

Two jabs offer little protection against Omicron infection, UK data shows

Two jabs offer little protection against Omicron infection, UK data shows

Health agency says booster raises protection as new daily infection figure rises to highest since January
Having two doses of a Covid vaccine offers less defence against symptomatic infection from the Omicron variant than with Delta, experts have said, although a booster jab raises protection considerably.

The UK Health Security Agency (UKHSA) said Omicron was projected to become the dominant variant of coronavirus in the UK by mid-December, based on current trends.

It added that there could be more than a million coronavirus infections by the end of the month.

Dr Susan Hopkins, the UKHSA’s chief medical adviser, said: “I think what we’re seeing is that if you’ve had two doses more than three months ago, then it’s not going to prevent you from getting symptomatic disease.”

However, a Pfizer/BioNTech booster jab, given after an initial round of either Oxford/AstraZeneca or Pfizer, raised the level of protection, offering 70-75% protection against symptomatic infection.

The findings came as the UK reported 58,194 new cases of Covid-19 on Friday – the highest number of positive cases in a 24-hour period since 9 January – and 120 deaths. A total of 448 Omicron cases were also reported, compared with 249 on Thursday, with the total across the UK to date now standing at 1,265.

The UKHSA report offers early insights into the degree of protection the initial two vaccinations may offer against Omicron. The data suggests that people who have had two doses of the Oxford/AstraZeneca jab 25 or more weeks ago have far lower protection against symptomatic infection with Omicron than with Delta.

While the data suggests such individuals have about 40% protection against Delta at this time point, protection against symptomatic infection with Omicron could be less than 10%. However, there is a great deal of uncertainty around that figure given the small number of people studied and the fact that the Oxford/AstraZeneca jab was largely given to older or more vulnerable people.

A similar trend was seen for those who have had two doses of the Pfizer jab, with about 60% protection against Delta at 25 or more weeks since the second dose, and just under 40% protection against Omicron at the same time point – although, again, there are uncertainties around the figures.

About 44 million people received their second jab at least three months ago, but about 22 million have received a booster since then.

Experts have said Omicron infections are doubling every two to three days in the UK, leading to concerns that the variant could overwhelm the NHS if it is as virulent as Delta. In the UK, about 39% of those over 12 years old have had a booster dose, compared with 81% of people having had two doses.

“The booster is really adding to protection,” said Dr Mary Ramsay, the head of immunisation at the UKHSA.

While the effectiveness of the jabs against severe disease is still unknown, the team says it is expected to be higher, drawing parallels to the drop in vaccine effectiveness for Delta when compared with earlier variants.

“We did see this reduction in protection against milder disease with Delta way back in June. And what we didn’t see was any reduction in protection against hospitalisation,” said Ramsay.

This is important because experts have previously warned that a drop in effectiveness against severe infections from, for example, 96% to 92% could lead to double the number of people who are not protected against hospitalisation.

While some data from South Africa has suggested that infections with Omicron may be mild, Hopkins said it was too early to know whether the variant causes less severe disease than Delta.

The findings chime with a report by scientists on Friday of the first cluster of Omicron cases in a group of people who had all received booster doses, suggesting that even three doses does not always protect against symptomatic illness.

The group of seven German tourists in their 20s and 30s had recently visited South Africa and were subsequently found to have been infected with Omicron. All had mild to moderate symptoms and were not admitted to hospital, but the findings contrast slightly with more encouraging early laboratory results released by BioNTech and Pfizer this week.

Prof Wolfgang Preiser, of Stellenbosch University in South Africa and senior author of the report on the cluster of Omicron cases, said: “We regard any claim that three doses would protect against symptomatic infection as not supported by available evidence.

“But importantly the message is not that vaccination does not work – it just does not work as well as it used to against pre-Omicron viruses and an updated vaccine is desirable.”
Newsletter

Related Articles

0:00
0:00
Close
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
×